Cyclooxygenase-2 (COX-2) and pro-inflammatory cytokine axis (COX-2/Cytokine axis)

The Cyclooxygenase-2 (COX-2) and pro-inflammatory cytokine axis is a complex signaling network central to the initiation and resolution of inflammation. COX-2, also known as Prostaglandin-endoperoxide synthase 2, is an inducible enzyme that catalyzes the rate-limiting step in the synthesis of prostaglandins, which are potent lipid mediators of pain, fever, and inflammation (StatPearls, 2023). This enzyme's expression is primarily driven by pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1 beta (IL-1 beta) through pathways like NF-kappaB, creating a potent inflammatory loop (PubMed, 10648000). Dysregulation of this axis is a hallmark of chronic inflammatory diseases like rheumatoid arthritis and is heavily implicated in the microenvironment of various cancers, where it promotes angiogenesis and immune evasion (Nature Reviews Cancer, 2001). Pharmacological intervention typically involves selective COX-2 inhibitors to reduce prostaglandin levels or biologic agents that neutralize specific cytokines to break the inflammatory cycle. However, modulating this axis requires careful management of side effects, particularly the cardiovascular risks associated with COX-2 inhibition and the immunosuppressive effects of cytokine blockade.

Other names

PTGS2 and cytokine signaling pathwayCOX-2/PGE2/cytokine axisProstaglandin-endoperoxide synthase 2 and inflammatory cytokine network

Inhibition of the COX-2 enzyme to prevent prostaglandin E2 synthesis and antagonism of pro-inflammatory cytokines (e.g., TNF-alpha, IL-1, IL-6) or their receptors to interrupt the inflammatory signaling cascade.